NEW YORK, Oct. 6, 2025 — OraLiva, Inc., an AI precision diagnostics company, today announced the close of a $2.0 million oversubscribed Seed financing round. The round was led by angel Dr. Preetpal Sidhu, with participation from DCVC, RTP Angel Fund, and the NYU Innovation Venture Fund. The equity financing complements $3.5 million in non-dilutive […]
Aided by Recent NIH Funding, OraLiva Prepares to Launch Oral Cancer Test
OraLiva, Inc. is preparing to launch its first noninvasive, AI-powered oral cancer test following recent NIH funding support. The test combines microfluidics, cytology, and advanced image analysis to detect mild-to-severe dysplasia earlier and more accurately than visual exams alone.
The platform is also being developed into a cartridge-based, point-of-care device that can be used directly in dental and ENT offices, with an FDA submission planned in the coming years
Beyond the Bench: How OraLiva Is Redefining Oral Cancer Diagnostics
OraLiva, Inc. is on the cusp of launching an AI-powered cytology “lab-in-a-kit” platform aimed at transforming early oral cancer diagnosis. The system captures cells via a non-invasive brush biopsy, runs them through OraLiva’s proprietary AI engine and compares the sample against a deep clinical dataset to detect early dysplasia or malignancy with high precision.
OraLiva Awarded NIH Grant to Advance AI-Driven Oral Health Innovation
OraLiva, Inc. has been awarded a prestigious Direct to Phase II SBIR grant from the National Institute of Dental and Craniofacial Research (NIDCR) at the National Institutes of Health (NIH). This funding supports the continued development of our groundbreaking AI-linked cytomics-on-a-chip platform.
Featured on the Slice of Healthcare podcast
OraLiva was recently featured on the Slice of Healthcare podcast. In this episode, Denise Marks of the CareQuest Institute of Oral Health and Dr. John T. McDevitt, founder of OraLiva, joined the discussion to share perspectives on advancing innovation in oral health diagnostics.
CareQuest Innovation Partners Case Study: OraLiva and the Future of Oral Cancer Diagnostics
OraLiva was recently highlighted by CareQuest Innovation Partners in their SMILE Health program case study. The feature outlines how OraLiva’s AI-powered brush biopsy is addressing the challenge of late oral cancer detection by bringing lab-quality cytology into the dental chair.
OraLiva featured in Becker’s Dental + DSO Review
OraLiva was recently featured in Becker’s Dental + DSO Review in an article by Cameron Cortigiano. The piece highlights the urgent need for improved oral cancer screening technology and how OraLiva is working to close that gap.